Fierce Pharma
AUGUST 20, 2024
Regulators in both the U.S. and Europe have looked into the potential link between suicidal thoughts and Novo Nordisk’s blockbuster semaglutide franchise after reports sounded the alarm last year. | Researchers found that users of Novo's semaglutide who were logged in a WHO database were more likely to report suicidal ideation.
MedCity News
AUGUST 20, 2024
In a Phase 3 study, Eli Lilly’s tirzepatide led to a 94% reduction in the risk that obese or overweight prediabetes patients progress to type 2 diabetes. Lilly was already planning to expand use of the blockbuster metabolic disorders drug to sleep apnea and heart failure. The post Eli Lilly Drug Reduces Risk of Diabetes Onset, Building Case for Broader Use of the Therapy appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
AUGUST 20, 2024
As House lawmakers prepare for a September vote on the controversial BIOSECURE Act, the House Select Committee on the CCP is expanding the scope of its scrutiny on China's biopharma ecosystem. | As House lawmakers prepare for a September vote on the controversial BIOSECURE Act, the House Select Committee on the CCP is expanding the scope of its scrutiny on China's biopharma ecosystem.
MedCity News
AUGUST 20, 2024
The lack of access to quality healthcare is often cited as the reason for maternal health disparities. But these issues go beyond access, according to Bayo Curry-Winchell, MD, founder of Beyond Clinical Walls and urgent care medical director at St. Mary’s Health Network. The post Maternal Health Crisis: Lack of Access to Care “Doesn’t Paint the Whole Picture,” Expert Says appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
AUGUST 20, 2024
Already wildly popular in type 2 diabetes and obesity, Eli Lilly’s tirzepatide can help prevent one of the very diseases it’s meant to treat, new data show. | Already wildly popular in type 2 diabetes and obesity, Eli Lilly’s tirzepatide can help prevent one of the very diseases it’s meant to treat, new data show.
Pharmaceutical Technology
AUGUST 20, 2024
The top 20 biopharmaceutical companies demonstrated resilience during the second quarter (Q2) of 2024 as global markets and investor optimism improved with anticipation of a potential interest rate cut from the US Federal Reserve.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 20, 2024
If enacted, the codes will represent the first major step toward broad-based reimbursement for digital therapeutics, and acknowledgement that CMS recognizes the substantial role new digital solutions can provide. The post Proposed Medicare Codes a Game-Changer for Digital Health appeared first on MedCity News.
Fierce Pharma
AUGUST 20, 2024
For years, Teva has been defending itself against allegations that it used illegal Medicare co-pay schemes to fuel sales of its multiple sclerosis drug Copaxone. | The new lawsuit, filed in a Kansas court, comes as Teva defends against similar allegations made by the U.S. government.
MedCity News
AUGUST 20, 2024
These strategies and practices can significantly shorten the life cycle of claims, leading to quicker resolutions and improved financial outcomes. The post Accelerating Claim Processing: Strategies to Shorten the Life of a Claim appeared first on MedCity News.
ALULA
AUGUST 20, 2024
Hybrid work continues to impact employees’ preferences, but how does it impact their leaders? In 2021, the World Trend Index reported that 73% of employees wanted flexible remote work options. The latest insights from Gallup show the number dipping only slightly to 60% today. Remote-capable employees are getting what they want , as most are working in a hybrid or exclusively remote arrangement.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
AUGUST 20, 2024
Three ways healthcare organizations can benefit from leveraging qualified revenue integrity professionals to enhance CDM technology and drive additional ROI The post Leveraging Experienced Revenue Integrity Professionals to Enhance CDM Technology appeared first on MedCity News.
pharmaphorum
AUGUST 20, 2024
Emergent BioSolutions has agreed to donate 50,000 doses of its mpox vaccine for use in the current outbreak, but an expert has warned supplies are unlikely to meet demand
MedCity News
AUGUST 20, 2024
After several quarters with little to no exit activity in the medtech space, several startups made exits in the second quarter of 2024, according to a new report. The post Public Exits Are Getting More Feasible In The Medtech Space appeared first on MedCity News.
PharmaVoice
AUGUST 20, 2024
Dr. Jennifer Low, head of 23andMe’s therapeutics division, is taking the company into new territory with a potential cancer treatment that targets a unique pathway.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
AUGUST 20, 2024
Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese adults with pre-diabetes.There's plenty of evidence to show that prediabetes – a higher-than-normal blood sugar level resulting from a level of insulin resistance that isn't high enough to be considered full-blown diabetes – can be reversed if patients commit to an intensive regimen of dietary restriction
Pharmaceutical Technology
AUGUST 20, 2024
Supplies of Emergent’s smallpox vaccine ACAM2000 will accompany Bavarian Nordic’s vaccine to African countries.
pharmaphorum
AUGUST 20, 2024
Danish biotech Adcendo has accelerated its progression to a clinical-stage biotech by licensing an antibody-drug conjugate (ADC) from China's Multitude Therapeutics with potential in various forms of cancer.Copenhagen-based Adcendo is paying what is rumours to be tens of millions of dollars in upfront fees for rights to Multitude's anti-tissue factor (TF) ADC AMT-754 – now renamed ADCE-T02 – outside mainland China, Hong Kong, Macau, and Taiwan.
PharmaTimes
AUGUST 20, 2024
The company’s Cell & Gene Therapy Centre can now offer a full range of GMP services
pharmaphorum
AUGUST 20, 2024
GSK gets FDA breakthrough status for its B7-H3 directed ADC, licensed from Hansah Pharma in a $1.
Pharmaceutical Commerce
AUGUST 20, 2024
The latest news for pharma industry insiders.
pharmaphorum
AUGUST 20, 2024
Avidity Bio raises $345m from its second big public offering of 2024, after reporting encouraging Duchenne muscular dystrophy data.
Pharmaceutical Technology
AUGUST 20, 2024
On July 2024, Colombia's President Gustavo Petro signed Law 2386 of 2024, which declared the pharmaceutical sector as strategic, at least in writing.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
pharmaphorum
AUGUST 20, 2024
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jane Reed, director of life sciences at Linguamatics, an IQVIA company, to discuss some of the major barriers preventing researchers from accessing the data they need to advance drug discovery and development and address safety concerns – and just how AI technologies can assist.
Clarify Health
AUGUST 20, 2024
Within healthcare, harnessing data effectively is crucial for any organization striving to deliver exceptional patient care, drive operational efficiency, and remain competitive. Safe to say, the last several years have been extraordinarily difficult for health systems – in 2023 alone, 40% of health systems were not profitable. More than ever, these circumstances underpin the necessity for organizations to leverage the best and most reliable data in order to continue delivering the best care pos
Scott’s Directories
AUGUST 20, 2024
Telemedicine is becoming increasingly vital in healthcare delivery, especially in Alberta, where distances between patients and doctors can be vast. As this technology continues to evolve, tools like the Alberta Physicians directory ensure that patients and healthcare professionals can connect. This directory offers an extensive list of physicians across Alberta.
Clarify Health
AUGUST 20, 2024
Within healthcare, harnessing data effectively is crucial for any organization striving to deliver exceptional patient care, drive operational efficiency, and remain competitive. Safe to say, the last several years have been extraordinarily difficult for health systems – in 2023 alone, 40% of health systems were not profitable. More than ever, these circumstances underpin the necessity for organizations to leverage the best and most reliable data in order to continue delivering the best care pos
PharmaTech
AUGUST 20, 2024
Fasenra, which has been approved since 2019 in the United States in a pre-filled, single-use auto-injector form that can be administered either in a doctor’s office or at home, is now approved in China for age 12 and up.
Clarify Health
AUGUST 20, 2024
Within healthcare, harnessing data effectively is crucial for any organization striving to deliver exceptional patient care, drive operational efficiency, and remain competitive. Safe to say, the last several years have been extraordinarily difficult for health systems – in 2023 alone, 40% of health systems were not profitable. More than ever, these circumstances underpin the necessity for organizations to leverage the best and most reliable data in order to continue delivering the best care pos
PharmExec
AUGUST 20, 2024
The acquisition, valued at $600 million, is expected to integrate V-Wave into Johnson & Johnson MedTech, which could improve the treatment of heart failure with reduced ejection fraction.
European Pharmaceutical Review
AUGUST 20, 2024
Eli Lilly and Company has released positive topline data from the longest completed trial of tirzepatide (Zepbound ® and Mounjaro ® ) to date. The GIP and GLP-1 receptor agonist was evaluated over 176-weeks compared to placebo in adults with pre-diabetes and obesity or overweight. The aim of the study was to assess its efficacy and safety for long-term weight management and for delaying the participants progression to diabetes.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
349 
Let's personalize your content